Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study

Table 4 Bivariate and multivariate logistic regression analyses of factors associated with glycemic control among patients with T2DM in TASH, Addis Ababa, Ethiopia, 2021

Variable	Category	Glycemic control (HbA1c)		Bivariate Analysis		Multivariate Analysis
Variable	Category	Good (< 7%) n = 85	Inadequate-poor (≥ 7%) n = 240	COR (95% CI)	P-value	AOR (95% CI)	P-value
Age group (yrs.)	18-44	26	48	1	-	1	-
	45-54	26	66	0.74 (0.39–1.18)	0.042*	1.63 (0.66–4.18)	0.11
	55-64	16	85	1.90 (1.10–3.20)	0.002*	2.46 (1.28–6.01)	0.03*
	≥ 65	17	41	1.72 (1.02–3.06)	0.008*	1.97 (1.30–5.97)	0.04*
DM duration	≤ 10 years	72	100	1	-	1	-
DM duration	> 10 years	33	120	1.62 (1.13–3.43)	0.001*	3.15 (2.22–6.54)	0.016*
Mode of therapy	Oral hypoglycemic agents (OHA)	46	47	1	-	1	-
	Insulin	41	104	2.50 (1.30–4.50)	0.001*	3.07 (2.10–6.12)	0.022*
	OHA & Insulin	25	50	1.12 (0.24–3.72)	0.029*	2.36 (0.82–5.97	0.073
	Diet modification/Exercise alone	11	1	0.52 (0.38–2.88)	0.054	0.91 (0.52–3.53)	0.160
Diet adherence	> 3 days/week	80	88	1	-	1	-
Diet adherence	0-3 days/week	45	112	2.32 (1.35–3.99)	0.001*	1.97 (1.28–3.52)	0.002*
Glycemic target goal (HbA1c/FBS/RBS)	Yes	82	47	1	-	1	-
Glycemic target goal (HbA1c/FBS/RBS)	No	49	147	2.61 (1.90–4.82)	0.001*	3.42 (2.17–5.97)	0.001*

ISSN: 1472-6823